Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Wintrust Financial
WTFC
$10.2B
| $14.4M | 0.01% |
198,889
-787,820
| -80% | -$53.7M |
|
1652
CDW
CDW
$17.8B
| $14.4M | 0.01% |
78,653
+48,328
| +159% | +$8.44M |
|
1653
PUT
Fortinet
FTNT
$113B
| $14.4M | 0.01% |
190,600
+180,600
| +1,806% | +$12.3M |
|
1654
Apogee Enterprises
APOG
$861M
| $14.4M | 0.01% |
303,143
-148,542
| -33% | -$6.2M |
|
1655
Super Micro Computer
SMCI
$24.9B
| $14.4M | 0.01% |
576,840
+141,070
| +32% | +$2.36M |
|
1656
Badger Meter
BMI
$3.95B
| $14.4M | 0.01% |
+97,387
| New | +$13.4M |
|
1657
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
| $14.3M | 0.01% |
143,434
+97,338
| +211% | +$9.67M |
|
1658
PUT
Western Alliance Bancorporation
WAL
$8.69B
| $14.3M | 0.01% |
392,000
+242,000
| +161% | +$8.39M |
|
1659
Alnylam Pharmaceuticals
ALNY
$32.1B
| $14.2M | 0.01% |
74,980
+51,606
| +221% | +$10.2M |
|
1660
Oceaneering
OII
$4.97B
| $14.2M | 0.01% |
760,427
-165,549
| -18% | -$2.85M |
|
1661
CALL
US Bancorp
USB
$97.2B
| $14.2M | 0.01% |
430,300
-582,500
| -58% | -$18.8M |
|
1662
Castle Biosciences
CSTL
$1.07B
| $14.2M | 0.01% |
1,035,593
+210,156
| +25% | +$4.26M |
|
1663
Burford Capital
BUR
$982M
| $14.2M | 0.01% |
1,165,123
+997,409
| +595% | +$12.9M |
|
|
THS
1664
DELISTED
Treehouse Foods
THS
| $14.2M | 0.01% |
281,345
-526,797
| -65% | -$27M |
|
1665
Laureate Education
LAUR
$5.28B
| $14.1M | 0.01% |
1,169,293
+491,565
| +73% | +$5.89M |
|
1666
AngioDynamics
ANGO
$659M
| $14.1M | 0.01% |
1,355,309
+174,498
| +15% | +$1.68M |
|
1667
PUT
S&P Global
SPGI
$128B
| $14.1M | 0.01% |
35,200
+28,900
| +459% | +$10.6M |
|
1668
Denali Therapeutics
DNLI
$3.98B
| $14.1M | 0.01% |
478,186
+91,897
| +24% | +$2.58M |
|
1669
American Homes 4 Rent
AMH
$12.4B
| $14.1M | 0.01% |
397,652
+380,218
| +2,181% | +$12.9M |
|
1670
CALL
Duke Energy
DUK
$94.8B
| $14.1M | 0.01% |
157,000
-35,900
| -19% | -$3.39M |
|
1671
MasterBrand
MBC
$1.84B
| $14M | 0.01% |
1,202,587
+7,011
| +0.6% | +$67.2K |
|
1672
ESAB
ESAB
$5B
| $14M | 0.01% |
209,857
+136,629
| +187% | +$8.29M |
|
1673
Bath & Body Works
BBWI
$3.54B
| $14M | 0.01% |
372,358
-222,971
| -37% | -$8.15M |
|
1674
ONE Gas
OGS
$5.05B
| $13.9M | 0.01% |
181,513
+13,011
| +8% | +$1.04M |
|
1675
PUT
AT&T
T
$177B
| $13.9M | 0.01% |
873,100
+740,400
| +558% | +$12.6M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.